sazaldous.bsky.social
@sazaldous.bsky.social
Researcher at UCL HD centre. Science, sport, and books
Reposted
🧵 BREAKING: Gene therapy shows promise in slowing Huntington’s disease progression. A major milestone in neurodegenerative disease research. @uclqsion.bsky.social @ucl-hd.bsky.social
www.bbc.co.uk/news/article...
Huntington's disease successfully treated for first time
One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful doctors tell BBC.
www.bbc.co.uk
September 24, 2025 at 2:25 PM
BBC News - Huntington's disease successfully treated for first time - BBC News
www.bbc.co.uk/news/article...
Huntington's disease successfully treated for first time
One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful doctors tell BBC.
www.bbc.co.uk
September 24, 2025 at 1:01 PM
Reposted
UCL HD Centre @ucl-hd.bsky.social celebrating #HDGratitudeDay. Thanks to all the families and researchers around the world who together are trying to improve lives for people with Huntington’s disease.
March 24, 2025 at 4:42 PM
Reposted
Today is #RareDiseaseDay2025!
We're shining a spotlight on the work of @qs-neurogenetics.bsky.social and their International partners whose relentless efforts are reshaping the landscape of rare disease science. @uclqsion.bsky.social
World Rare Disease Day 2025 - Advancing Rare Disease Research Through Global Partnerships
For World Rare Disease Day 2025, the Neurogenetics Lab at UCL Queen Square Institute of Neurology is celebrating the invaluable contributions of our international collaborators, whose dedication is…
buff.ly
February 28, 2025 at 3:43 PM
Reposted
Exciting news! Our latest paper is out today in @ScienceTM — 'Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC–derived striatal neurons' 🧬 www.science.org/doi/10.1126/... @uclqsion.bsky.social @uclbrainscience.bsky.social
Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC–derived striatal neurons
MSH3 lowering by antisense oligonucleotides dose-dependently reduces CAG repeat expansions in iPSC-derived neurons from a patient with HD.
www.science.org
February 12, 2025 at 7:39 PM
Reposted
Our paper in Nature Medicine is out today! Great working with @drmfarag.bsky.social & the YAS team (researchers and participants) to identify biomarkers that pave the way for preventative trials in Huntington's Disease. Thanks to @wellcometrust.bsky.social and CHDI for funding. tinyurl.com/3fde9mth
January 17, 2025 at 3:31 PM
The change from xmas exams to xmas marking! Career progress! (?)
December 12, 2024 at 2:56 PM